Clinical trial
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal…
NCT00424242 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00424242 |
|---|---|
| Title | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases |
| Official title | A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis and 2 more |
| Intervention type | Drug |
| Interventions | Pemetrexed |
| Enrollment | 15 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Sep 1, 2011 |
| First posted | Jan 18, 2007 |
| Last update posted | Sep 8, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: